The present invention relates to shoulder implants. In particular, the present invention relates to glenoid implants for shoulder joints having scapula erosion and devices that facilitate implanting the same.
In a healthy shoulder joint, the head of the humerus interacts with the glenoid cavity of the scapula to form a “ball and socket” joint. The humeral head abuts and articulates with the glenoid to provide a wide range of motion. In an unhealthy shoulder joint, the interaction between the glenoid and the humerus is compromised, requiring repair or replacement.
Replacing the glenoid articular surface of the scapula of a human with a prosthetic glenoid component is a delicate surgical operation, notably because of the muscular environment of the shoulder. It is found that, depending on the position of implantation of such a glenoid component, risks of separation of the component from the underlying scapula exist due to forces applied to this component in subsequent movements of the prosthesized shoulder. In particular, in certain patients, it was found that, even if the implantation on their scapula of such a glenoid component was perfectly centered on the articular head of the corresponding humerus on completion of the surgical implantation operation, the resumption of their activities led, more or less rapidly, to instability of the prosthesis.
Currently, several companies are working on custom devices to guide glenoid bone preparation. One example filed by Tornier, Inc. is U.S. patent application Ser. No. 12/954,423, filed 24 Nov. 2010 and published as US 2011/0130795 A1.
A patient specific glenoid guide is provided to facilitate properly aligned implantation of a glenoid prosthesis into a patient. The guide shape is designed preoperatively based on the unique configuration of the scapula of the patient. The guide orientation is chosen preoperatively based on one or more of the bone structure of the patient, the wear pattern of the patient's glenoid cavity, the anchoring means of the glenoid prosthesis, or other aspects.
The guide may reversibly snap into securement with the scapula of the patient to hold the guide to the scapula during surgery. The guide may establish one or more axes through the shoulder joint about which subsequent bone preparation procedures and prosthesis implantation may be carried out. The guide may allow insertion of one or more K-wires or pins through the guide and into the scapula along the axis, and also allow removal of the guide without removing the one or more K-wires or pins.
The patient specific glenoid guide may be comprised of a central tubular element and three or more peripheral arms emanating from the central tubular element. One or more arms may terminate in a peripheral peg. One or more peripheral peg may be configured to reversibly engage with the scapula of the patient. The guide may be made by rapid prototyping or three dimensional printing methods.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
As part of the process for restoring a functional articular surface to the scapula a glenoid implant is firmly attached to the scapula by a fixation means (not shown). In some examples the fixation means comprises one or more screws, pegs, keels, fins, cement, or other fixation means. It is desirable to establish proper orientation of the glenoid implant in relation to the scapula and the humerus to assure that the fixation means has adequate strength to resist implant dislodgement from forces generated by articular motions of the joint. For example, screws must have adequate pull-out strength to resist articular forces of the joint that tend to dislodge the implant from the shoulder bones. Further, proper orientation of the glenoid implant in relation to the scapula and the humerus can minimize the forces generated on the glenoid implant during articulation of the shoulder joint. To facilitate proper orientation of the glenoid implant an axis through the shoulder joint can be established and the axis used to properly orient the glenoid implant so as to accomplish the above goals.
Another part of the process for properly fitting a glenoid implant to the scapula can be preparing the worn surface of the scapula so that the prepared surface will match a previously prepared surface of the glenoid implant. A surgeon may need to remove a significant amount of bone including cortical bone of the relatively healthy portions of the glenoid to accommodate typical glenoid implants. When these matched surfaces are brought into apposition the combination will resist rocking, sliding, twisting, and other articular motions of the joint that tend to dislodge the implant from the shoulder bones. To facilitate proper orientation of the glenoid implant an axis through the shoulder joint can be established and the axis used to guide scapula surface preparation tools such as reamers, guides, broaches and other devices so as to accomplish the above goals.
Central tubular element 110 is comprised of lumen 112 having axis X-X and is designed to guide a drill bit (not shown) for drilling a hole in the scapula. In another embodiment central tubular element 110 is designed to guide an alignment pin (not shown) through lumen 112 along axis X-X.
In a further embodiment (see
At least three arms 120 are provided on the guide, four arms are preferred, and 5, 6, 7, or 8 arms are contemplated. The arms between the central tubular element and each peripheral peg may have an elliptical, round, ovoid, polygonal, square, rectangular, triangular, other cross-section. In one embodiment the arm has an elliptical cross section and the major axis of the ellipse is perpendicular to the glenoid surface, the major axis is about 5 mm in length and the minor axis is about 4 mm in length. Arm 120 has a cross sectional area 122. Arm cross sectional areas of 10 square millimeters to 40 square millimeters and any cross sectional area therebetween are contemplated.
Peripheral peg 130 is comprised of identifier 132 and engagement surface 134. At least three pegs are provided on the guide, four pegs are preferred, and 5, 6, 7, or 8 pegs are contemplated. Three pegs are positioned to engage the anterior border of the glenoid cavity while one peg is positioned to engage the supero-posterior border of the glenoid cavity. Opposite to peg engagement surface 134, on the peg lateral extremity, the pegs are marked with identifier 132. In some embodiments anterior pegs are marked with identifier “A” while posterior pegs are marked with identifier “P”. Peg diameters of 6 mm to 10 mm and any diameter therebetween are contemplated. In one embodiment peg diameter is 8 mm. In another embodiment the posterior peg axis P-P is angled at an obtuse angle α from the arm so as to not be in conflict with the posterior retractor during the arthroplasty procedure. Engagement surface 134 may be customized to closely conform to the 3 dimensional shape of the border of the glenoid cavity.
Patient specific glenoid guide 100 optionally comprises handle 116 (
Patient specific glenoid guide 100 optionally comprises strut 140 having slot 142 (
In a further embodiment (not shown), second guide 100′ is associated with first guide 100. Second guide 100′ is similar to first guide 100 except that second guide 100′ is designed to fit the patient's scapula after the scapula shape has been modified, for example, modified by reaming, and central tubular element 110′ is comprised of two or more lumens 112′, 112″ having axes parallel to axis X-X. In some embodiment's lumens 112′, 112″ may be used to guide a drill bit (not shown) for drilling at least 2 holes in the scapula.
Guide 100 can be made by molding, machining, casting, thermal forming, or by other methods. In one embodiment guide 100 is made by rapid prototyping techniques, additive manufacturing or three dimensional printing using methods such as stereolithography or laser sintering. Guide 100 can be comprised of thermoplastics such as polyamide (such as PA2200 by Arptech) or metals such as titanium or stainless steel, or other materials.
Guide 100 is designed from three dimensional (3D) data about the anatomy of a patient's shoulder. The position and orientation of the axis X-X of the central tubular element 110 is defined according to pre-operative planning. The design process reproduces the translational positions of the glenoid component on three axes, (the antero-posterior axis, the supero-inferior axis and the medio-lateral axis) and it also reproduces the rotational positions of the glenoid component around the same three axes (supero-inferior axis (version), antero-posterior axis (inclination), and the medio-lateral axis (rotation)). By visualizing all of these positions a best choice position and orientation of axis X-X can be selected before operating on the patient. Also, a variety of glenoid implants can be evaluated for compatibility and performance in relation to the patients specific anatomy.
In one exemplar embodiment a three dimensional model of the patients shoulder is generated from imaging data obtained using a medical imaging technique such as a CT scan or a MRI. The imaging data are processed manually or automatically to generate a 3D model of the patient's scapula. From the 3D model of the patient's scapula, patient-specific guide 100 is designed automatically or manually using various CAD programs and/or software available such as Solid Works or ProEngineer.
A non-limiting exemplar method of use of the patient specific glenoid guide is now described.
Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments.
The term “about” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the term “about” may refer to an amount that is within less than 10% of the stated amount, as the context may dictate.
Any methods disclosed herein need not be performed in the order recited. The methods disclosed herein include certain actions taken by a practitioner; however, they can also include any third-party instruction of those actions, either expressly or by implication. For example, actions such as “positioning three pegs around an anterior anatomical feature adjacent of the a glenoid cavity” include “instructing the positioning of three pegs around an anterior anatomical feature adjacent of the a glenoid cavity.”
Although certain embodiments and examples have been described herein, it will be understood by those skilled in the art that many aspects of the glenoid guide shown and described in the present disclosure may be differently combined and/or modified to form still further embodiments or acceptable examples. All such modifications and variations are intended to be included herein within the scope of this disclosure. A wide variety of designs and approaches are possible. No feature, structure, or step disclosed herein is essential or indispensable.
Some embodiments have been described in connection with the accompanying drawings. However, it should be understood that the figures are not drawn to scale. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein. Additionally, it will be recognized that any methods described herein may be practiced using any device suitable for performing the recited steps.
For purposes of this disclosure, certain aspects, advantages, and novel features are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, for example, those skilled in the art will recognize that the disclosure may be embodied or carried out in a manner that achieves one advantage or a group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
Moreover, while illustrative embodiments have been described herein, the scope of any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations as would be appreciated by those in the art based on the present disclosure. The limitations in the claims are to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive. Further, the actions of the disclosed processes and methods may be modified in any manner, including by reordering actions and/or inserting additional actions and/or deleting actions. It is intended, therefore, that the specification and examples be considered as illustrative only, with a true scope and spirit being indicated by the claims and their full scope of equivalents.
The following example embodiments identify some possible permutations of combinations of features disclosed herein, although other permutations of combinations of features are also possible.
1. A patient specific glenoid guide for attachment to a scapula of a patient, the glenoid guide comprising:
2. The patient specific glenoid guide of Embodiment 1, wherein the guide feature comprises a central tubular element that comprises a lumen.
3. The patient specific glenoid guide of Embodiment 1 or 2, wherein the guide feature is tapered.
4. The patient specific glenoid guide of any one of Embodiments 1 to 3, wherein the guide feature is configured to receive a pin guide.
5. The patient specific glenoid guide of any one of Embodiments 1 to 4, wherein the at least three peripheral pegs comprises four peripheral pegs.
6. The patient specific glenoid guide of Embodiment 5, wherein three of the four peripheral pegs are configured to engage an anterior anatomical feature of the scapula, and wherein one of the four peripheral pegs is configured to engage a supero-posterior anatomical feature of the scapula.
7. The patient specific glenoid guide of Embodiment 6, wherein three of the four peripheral pegs are configured to engage an anterior border of a glenoid cavity, and wherein one of the four peripheral pegs is configured to engage a supero-posterior border of the glenoid cavity.
8. The patient specific glenoid guide of any one of Embodiments 1 to 7, wherein each of the at least three arms comprises an elliptical cross section, the major axis of the elliptical cross-section being perpendicular to a glenoid cavity when the glenoid guide is coupled with the scapula.
9. The patient specific glenoid guide of any one of Embodiments 1 to 8, wherein an angle between one of the at least three arms and a corresponding peg is an obtuse angle.
10. The patient specific glenoid guide of any one of Embodiments 1 to 9, further comprising a lateral handle extending laterally from the guide feature.
11. The patient specific glenoid guide of any one of Embodiments 1 to 10, further comprising a strut extending laterally from the guide feature, the strut comprising a slot.
12. A system for guiding a glenoid prosthesis, the system comprising:
13. The system of Embodiment 12, wherein the pin guide comprises a tapered surface, and wherein the guide feature is tapered to receive the tapered pin guide.
14. A surgical kit comprising:
15. The surgical kit of Embodiment 14, wherein the guide feature comprises a central tubular element that comprises a lumen.
16. The surgical kit of Embodiment 14 or 15, wherein the guide feature is tapered.
17. The surgical kit of any one of Embodiments 14 to 16, wherein the guide feature is configured to receive a pin guide.
18. The surgical kit of any one of Embodiments 14 to 17, wherein the plurality of peripheral pegs comprises four peripheral pegs.
19. The surgical kit of Embodiment 18, wherein three of the four peripheral pegs are configured to engage an anterior portion of the glenoid cavity border, and wherein one of the four peripheral pegs is configured to engage a supero-posterior portion of the glenoid cavity border.
20. The surgical kit of any one of Embodiments 14 to 19, wherein each of the plurality of arms comprises an elliptical cross section, the major axis of the elliptical cross-section being perpendicular to a portion of the model corresponding to a glenoid cavity when the guide is applied to the model.
21. The surgical kit of any one of Embodiments 14 to 20, wherein an angle between one of the plurality of peripheral pegs and the corresponding arms is an obtuse angle.
22. The surgical kit of any one of Embodiments 14 to 21, further comprising a lateral handle extending laterally from the guide feature.
23. The surgical kit of any one of Embodiments 14 to 22, further comprising a strut extending laterally from the guide feature, the strut comprising a slot.
24. The surgical kit of any one of Embodiments 14 to 23, further comprising a pin guide coupled to the guide feature.
25. A method of guiding a glenoid prosthesis, the method comprising:
26. The method of Embodiment 25, wherein the guide feature comprises a central tubular element that comprises a lumen and inserting the pin comprises inserting the pin through the lumen of the guide feature.
27. The method of Embodiment 25 or 26, wherein engaging the glenoid guide with the scapula comprises engaging the glenoid guide with a glenoid cavity border by snap fit.
28. The method of any one of Embodiments 25 to 27, wherein engaging the glenoid guide with the scapula comprises positioning three pegs around an anterior anatomical feature of a glenoid cavity and positioning one peg at a supero-posterior anatomical feature of the glenoid cavity.
29. The method of Embodiment 28, wherein engaging the glenoid guide with the scapula comprises positioning three pegs around an anterior anatomical border of the glenoid cavity and positioning one peg at a supero-posterior border of the glenoid cavity.
30. The method of any one of Embodiments 25 to 29, further comprising advancing the glenoid prosthesis along the pin.
31. The method of any one of Embodiments 25 to 30, further comprising securing the pin to the guide feature by a friction fit.
32. The method of any one of Embodiments 25 to 30, further comprising securing a conical taper of the pin with a conical taper of the guide feature.
The present application is a divisional of U.S. application Ser. No. 16/521,466, filed on Jul. 24, 2019, which is a divisional of U.S. application Ser. No. 15/024,747, filed on Mar. 24, 2016, now U.S. Pat. No. 10,405,993, which is a national phase of PCT International Application No. PCT/IB2014/002711, filed on Nov. 11, 2014, which claims priority benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 61/903,814, filed on Nov. 13, 2013, both of which are incorporated by reference in their entirety herein. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
Number | Name | Date | Kind |
---|---|---|---|
4919670 | Dale et al. | Apr 1990 | A |
5030219 | Matsen, III et al. | Jul 1991 | A |
5329846 | Bonutti | Jul 1994 | A |
5370692 | Fink et al. | Dec 1994 | A |
5383938 | Rohr et al. | Jan 1995 | A |
5531793 | Kelman et al. | Jul 1996 | A |
5610966 | Martell et al. | Mar 1997 | A |
5725586 | Sommerich | Mar 1998 | A |
5768134 | Swaelens et al. | Jun 1998 | A |
5769856 | Dong et al. | Jun 1998 | A |
5779710 | Matsen, III | Jul 1998 | A |
5807437 | Sachs et al. | Sep 1998 | A |
5824078 | Nelson et al. | Oct 1998 | A |
5824085 | Sahay et al. | Oct 1998 | A |
6002859 | DiGioia, III et al. | Dec 1999 | A |
6129764 | Servidio | Oct 2000 | A |
6155812 | Smith et al. | Dec 2000 | A |
6172856 | Jang | Jan 2001 | B1 |
6183519 | Bonnin et al. | Feb 2001 | B1 |
6364910 | Shultz et al. | Apr 2002 | B1 |
6385475 | Cinquin et al. | May 2002 | B1 |
6432142 | Kamiya et al. | Aug 2002 | B1 |
6459948 | Ateshian et al. | Oct 2002 | B1 |
6648894 | Abdelgany et al. | Nov 2003 | B2 |
6699289 | Iannotti et al. | Mar 2004 | B2 |
6719799 | Kropf | Apr 2004 | B1 |
6772026 | Bradbury et al. | Aug 2004 | B2 |
6797006 | Hodorek | Sep 2004 | B2 |
6915150 | Cinquin et al. | Jul 2005 | B2 |
6944518 | Roose | Sep 2005 | B2 |
7468075 | Lang et al. | Dec 2008 | B2 |
7469474 | Farrar | Dec 2008 | B2 |
7534263 | Burdulis, Jr. et al. | May 2009 | B2 |
7542791 | Mire et al. | Jun 2009 | B2 |
7599539 | Kunz et al. | Oct 2009 | B2 |
7618451 | Berez et al. | Nov 2009 | B2 |
7634119 | Tsougarakis et al. | Dec 2009 | B2 |
7648530 | Habermeyer et al. | Jan 2010 | B2 |
7678150 | Tornier et al. | Mar 2010 | B2 |
7717956 | Lang | May 2010 | B2 |
7747305 | Dean et al. | Jun 2010 | B2 |
7796791 | Tsougarakis et al. | Sep 2010 | B2 |
7799077 | Lang et al. | Sep 2010 | B2 |
7802503 | Couvillion et al. | Sep 2010 | B2 |
7822588 | Mueller et al. | Oct 2010 | B2 |
7831079 | Kunz et al. | Nov 2010 | B2 |
7927338 | Laffargue et al. | Apr 2011 | B2 |
7981158 | Fitz et al. | Jul 2011 | B2 |
7983777 | Melton et al. | Jul 2011 | B2 |
8007448 | Barrera | Aug 2011 | B2 |
8014984 | Iannotti et al. | Sep 2011 | B2 |
8055487 | James | Nov 2011 | B2 |
8062302 | Lang et al. | Nov 2011 | B2 |
8066708 | Lang et al. | Nov 2011 | B2 |
8077950 | Tsougarakis et al. | Dec 2011 | B2 |
8083745 | Lang et al. | Dec 2011 | B2 |
8094900 | Steines et al. | Jan 2012 | B2 |
8105330 | Fitz et al. | Jan 2012 | B2 |
8122582 | Burdulis, Jr. et al. | Feb 2012 | B2 |
8160325 | Zug et al. | Apr 2012 | B2 |
8160345 | Pavlovskaia et al. | Apr 2012 | B2 |
8175683 | Roose | May 2012 | B2 |
8214016 | Lavallee et al. | Jul 2012 | B2 |
8221430 | Park et al. | Jul 2012 | B2 |
8231634 | Mahfouz et al. | Jul 2012 | B2 |
8234097 | Steines et al. | Jul 2012 | B2 |
8337501 | Fitz et al. | Dec 2012 | B2 |
8337503 | Lian | Dec 2012 | B2 |
8337507 | Lang et al. | Dec 2012 | B2 |
8343218 | Lang et al. | Jan 2013 | B2 |
8350186 | Jones et al. | Jan 2013 | B2 |
8366771 | Burdulis, Jr. et al. | Feb 2013 | B2 |
8377073 | Wasielewski | Feb 2013 | B2 |
8377129 | Fitz et al. | Feb 2013 | B2 |
8382765 | Axelson et al. | Feb 2013 | B2 |
8439926 | Bojarski et al. | May 2013 | B2 |
8444651 | Kunz et al. | May 2013 | B2 |
8457930 | Schroeder | Jun 2013 | B2 |
8460304 | Fitz et al. | Jun 2013 | B2 |
8475463 | Lian | Jul 2013 | B2 |
8480753 | Collazo et al. | Jul 2013 | B2 |
8480754 | Bojarski et al. | Jul 2013 | B2 |
8500740 | Bojarski et al. | Aug 2013 | B2 |
8529568 | Bouadi | Sep 2013 | B2 |
8529630 | Bojarski et al. | Sep 2013 | B2 |
8532806 | Masson | Sep 2013 | B1 |
8532807 | Metzger | Sep 2013 | B2 |
8535319 | Ball | Sep 2013 | B2 |
8545509 | Park et al. | Oct 2013 | B2 |
8545569 | Fitz et al. | Oct 2013 | B2 |
8551099 | Lang et al. | Oct 2013 | B2 |
8551102 | Fitz et al. | Oct 2013 | B2 |
8551103 | Fitz et al. | Oct 2013 | B2 |
8551169 | Fitz et al. | Oct 2013 | B2 |
8556906 | Fitz et al. | Oct 2013 | B2 |
8556907 | Fitz et al. | Oct 2013 | B2 |
8556971 | Lang | Oct 2013 | B2 |
8556983 | Bojarski et al. | Oct 2013 | B2 |
8561278 | Fitz et al. | Oct 2013 | B2 |
8562611 | Fitz et al. | Oct 2013 | B2 |
8562618 | Fitz et al. | Oct 2013 | B2 |
8568479 | Fitz et al. | Oct 2013 | B2 |
8568480 | Fitz et al. | Oct 2013 | B2 |
8585708 | Fitz et al. | Nov 2013 | B2 |
8608749 | Meridew et al. | Dec 2013 | B2 |
8617172 | Fitz et al. | Dec 2013 | B2 |
8617242 | Philipp | Dec 2013 | B2 |
8623026 | Wong et al. | Jan 2014 | B2 |
8634617 | Tsougarakis et al. | Jan 2014 | B2 |
8634618 | Zug et al. | Jan 2014 | B2 |
8638998 | Steines et al. | Jan 2014 | B2 |
8641716 | Fitz et al. | Feb 2014 | B2 |
8657827 | Fitz et al. | Feb 2014 | B2 |
8663333 | Metcalfe et al. | Mar 2014 | B2 |
8682052 | Fitz et al. | Mar 2014 | B2 |
8690945 | Fitz et al. | Apr 2014 | B2 |
8709089 | Lang et al. | Apr 2014 | B2 |
8731885 | Iannotti et al. | May 2014 | B2 |
8734455 | Park et al. | May 2014 | B2 |
8735773 | Lang | May 2014 | B2 |
8744148 | Nord et al. | Jun 2014 | B2 |
8764836 | De Wilde et al. | Jul 2014 | B2 |
8768028 | Lang et al. | Jul 2014 | B2 |
8771365 | Bojarski et al. | Jul 2014 | B2 |
8774900 | Buly et al. | Jul 2014 | B2 |
8775133 | Schroeder | Jul 2014 | B2 |
8777875 | Park | Jul 2014 | B2 |
8801719 | Park et al. | Aug 2014 | B2 |
8808302 | Roose et al. | Aug 2014 | B2 |
8814942 | Anthony et al. | Aug 2014 | B2 |
8830233 | Friedland et al. | Sep 2014 | B2 |
8843229 | Vanasse et al. | Sep 2014 | B2 |
8864769 | Stone et al. | Oct 2014 | B2 |
8864834 | Boileau et al. | Oct 2014 | B2 |
8882847 | Burdulis, Jr. et al. | Nov 2014 | B2 |
8884618 | Mahfouz | Nov 2014 | B2 |
8888855 | Roche et al. | Nov 2014 | B2 |
8898043 | Ashby et al. | Nov 2014 | B2 |
8903530 | Metzger | Dec 2014 | B2 |
8906107 | Bojarski et al. | Dec 2014 | B2 |
8926706 | Bojarski et al. | Jan 2015 | B2 |
8932361 | Tornier et al. | Jan 2015 | B2 |
8932363 | Tsougarakis et al. | Jan 2015 | B2 |
8934961 | Lakin et al. | Jan 2015 | B2 |
8945230 | Lang et al. | Feb 2015 | B2 |
8951259 | Fitz et al. | Feb 2015 | B2 |
8951260 | Lang et al. | Feb 2015 | B2 |
8965088 | Tsougarakis et al. | Feb 2015 | B2 |
8971606 | Chaoui | Mar 2015 | B2 |
8974539 | Bojarski et al. | Mar 2015 | B2 |
8984731 | Broeck et al. | Mar 2015 | B2 |
8986309 | Murphy | Mar 2015 | B1 |
8989460 | Mahfouz | Mar 2015 | B2 |
8990052 | Lavallee et al. | Mar 2015 | B2 |
8992533 | Blain et al. | Mar 2015 | B2 |
8992538 | Keefer | Mar 2015 | B2 |
8998915 | Fitz et al. | Apr 2015 | B2 |
9011456 | Ranawat et al. | Apr 2015 | B2 |
9020788 | Lang | Apr 2015 | B2 |
9023050 | Lang et al. | May 2015 | B2 |
9055953 | Lang et al. | Jun 2015 | B2 |
9060788 | Bollinger | Jun 2015 | B2 |
9066728 | Burdulis, Jr. et al. | Jun 2015 | B2 |
9066806 | Phipps | Jun 2015 | B2 |
9072531 | Fitz et al. | Jul 2015 | B2 |
9084617 | Lang et al. | Jul 2015 | B2 |
9095353 | Burdulis, Jr. et al. | Aug 2015 | B2 |
9095375 | Haimerl et al. | Aug 2015 | B2 |
9107679 | Lang et al. | Aug 2015 | B2 |
9107680 | Fitz et al. | Aug 2015 | B2 |
9113921 | Lang et al. | Aug 2015 | B2 |
9125672 | Fitz et al. | Sep 2015 | B2 |
9126673 | Green et al. | Sep 2015 | B1 |
9138258 | Geebelen | Sep 2015 | B2 |
9180015 | Fitz et al. | Nov 2015 | B2 |
9186161 | Lang et al. | Nov 2015 | B2 |
9186254 | Fitz et al. | Nov 2015 | B2 |
9198732 | Iannotti et al. | Dec 2015 | B2 |
9204977 | Bollinger | Dec 2015 | B2 |
9211199 | Ratron | Dec 2015 | B2 |
9216025 | Fitz et al. | Dec 2015 | B2 |
9220516 | Lang et al. | Dec 2015 | B2 |
9220517 | Lang et al. | Dec 2015 | B2 |
9232955 | Bonin, Jr. et al. | Jan 2016 | B2 |
9237950 | Hensley et al. | Jan 2016 | B2 |
9241724 | Lang et al. | Jan 2016 | B2 |
9241725 | Lang et al. | Jan 2016 | B2 |
9278413 | Sperling | Mar 2016 | B2 |
9289221 | Gelaude et al. | Mar 2016 | B2 |
9295481 | Fitz et al. | Mar 2016 | B2 |
9295482 | Fitz et al. | Mar 2016 | B2 |
9301768 | Buza et al. | Apr 2016 | B2 |
9301812 | Kehres et al. | Apr 2016 | B2 |
9308005 | Fitz et al. | Apr 2016 | B2 |
9308053 | Bojarski et al. | Apr 2016 | B2 |
9308091 | Lang | Apr 2016 | B2 |
9314256 | Fitz et al. | Apr 2016 | B2 |
9320608 | Sperling | Apr 2016 | B2 |
9320620 | Bojarski et al. | Apr 2016 | B2 |
9326780 | Wong et al. | May 2016 | B2 |
9326862 | Smith et al. | May 2016 | B2 |
9333085 | Fitz et al. | May 2016 | B2 |
9345548 | Schoenefeld et al. | May 2016 | B2 |
9351743 | Kehres et al. | May 2016 | B2 |
9358018 | Fitz et al. | Jun 2016 | B2 |
9381025 | Fitz et al. | Jul 2016 | B2 |
9381026 | Trouilloud et al. | Jul 2016 | B2 |
9386994 | Agnihotri et al. | Jul 2016 | B2 |
9387083 | Al Hares et al. | Jul 2016 | B2 |
9402726 | Linderman et al. | Aug 2016 | B2 |
9408615 | Fitz et al. | Aug 2016 | B2 |
9408616 | Kehres et al. | Aug 2016 | B2 |
9408686 | Miller et al. | Aug 2016 | B1 |
9408698 | Miles et al. | Aug 2016 | B2 |
9414928 | Sperling | Aug 2016 | B2 |
9421021 | Keppler | Aug 2016 | B2 |
9439767 | Bojarski et al. | Sep 2016 | B2 |
9451973 | Heilman et al. | Sep 2016 | B2 |
9486226 | Chao | Nov 2016 | B2 |
9495483 | Steines et al. | Nov 2016 | B2 |
9498233 | Eash | Nov 2016 | B2 |
9498344 | Hodorek et al. | Nov 2016 | B2 |
9504579 | Mahfouz et al. | Nov 2016 | B2 |
9517134 | Lang | Dec 2016 | B2 |
9539013 | Katrana et al. | Jan 2017 | B2 |
9554910 | Vanasse et al. | Jan 2017 | B2 |
9575931 | Ratron | Feb 2017 | B2 |
9579106 | Lo et al. | Feb 2017 | B2 |
9579110 | Bojarski et al. | Feb 2017 | B2 |
9592128 | Phipps | Mar 2017 | B2 |
9597201 | Bollinger | Mar 2017 | B2 |
9603711 | Bojarski et al. | Mar 2017 | B2 |
9615834 | Agnihotri et al. | Apr 2017 | B2 |
9615840 | Iannotti et al. | Apr 2017 | B2 |
9636229 | Lang et al. | May 2017 | B2 |
9646113 | Park et al. | May 2017 | B2 |
9649170 | Park et al. | May 2017 | B2 |
9662214 | Li et al. | May 2017 | B2 |
9668873 | Winslow et al. | Jun 2017 | B2 |
9675461 | Mahfouz | Jun 2017 | B2 |
9675471 | Bojarski et al. | Jun 2017 | B2 |
9681956 | Al Hares et al. | Jun 2017 | B2 |
9684768 | Lavallee et al. | Jun 2017 | B2 |
9687945 | Steines et al. | Jun 2017 | B2 |
9693785 | Theiss et al. | Jul 2017 | B2 |
9700420 | Fitz et al. | Jul 2017 | B2 |
9700971 | Lang | Jul 2017 | B2 |
9713533 | Taylor et al. | Jul 2017 | B2 |
9713539 | Haimerl et al. | Jul 2017 | B2 |
9715563 | Schroeder | Jul 2017 | B1 |
9717508 | Iannotti et al. | Aug 2017 | B2 |
9737367 | Steines et al. | Aug 2017 | B2 |
9741263 | Iannotti et al. | Aug 2017 | B2 |
9757238 | Metzger | Sep 2017 | B2 |
9763682 | Bettenga | Sep 2017 | B2 |
9770335 | Sperling | Sep 2017 | B2 |
9775680 | Bojarski et al. | Oct 2017 | B2 |
9795393 | Hughes et al. | Oct 2017 | B2 |
9808261 | Gelaude et al. | Nov 2017 | B2 |
9814533 | Park et al. | Nov 2017 | B2 |
9820868 | Witt et al. | Nov 2017 | B2 |
9839438 | Eash | Dec 2017 | B2 |
9849019 | Miller et al. | Dec 2017 | B2 |
9872773 | Lang et al. | Jan 2018 | B2 |
9877790 | Bojarski et al. | Jan 2018 | B2 |
9895230 | Mahfouz | Feb 2018 | B2 |
9913691 | Brooks | Mar 2018 | B2 |
9913723 | Fitz et al. | Mar 2018 | B2 |
9925048 | Winslow et al. | Mar 2018 | B2 |
9936962 | Heilman et al. | Apr 2018 | B2 |
9937046 | Mahfouz | Apr 2018 | B2 |
9943370 | Asseln et al. | Apr 2018 | B2 |
9956047 | Bojarski et al. | May 2018 | B2 |
9956048 | Bojarski et al. | May 2018 | B2 |
9987024 | Frey et al. | Jun 2018 | B2 |
9993341 | Vanasse et al. | Jun 2018 | B2 |
10010334 | Keppler | Jul 2018 | B2 |
10010431 | Eraly et al. | Jul 2018 | B2 |
10019551 | Zellner et al. | Jul 2018 | B2 |
10085839 | Wong et al. | Oct 2018 | B2 |
10433969 | Humphrey | Oct 2019 | B2 |
10537390 | Varadarajan et al. | Jan 2020 | B2 |
10548737 | Hodorek et al. | Feb 2020 | B2 |
10722310 | Luby | Jul 2020 | B2 |
10736697 | Chaoui et al. | Aug 2020 | B2 |
10762623 | Geebelen et al. | Sep 2020 | B2 |
10842510 | Heilman et al. | Nov 2020 | B2 |
10842512 | Bonin, Jr. et al. | Nov 2020 | B2 |
10888378 | Walch | Jan 2021 | B2 |
10905562 | Sbaiz et al. | Feb 2021 | B2 |
10912571 | Pavlovskaia et al. | Feb 2021 | B2 |
10922448 | McKinnon et al. | Feb 2021 | B2 |
10925658 | Hopkins | Feb 2021 | B2 |
10973535 | Iannotti et al. | Apr 2021 | B2 |
10973580 | Berend et al. | Apr 2021 | B2 |
11033335 | Zhang | Jun 2021 | B2 |
11039889 | Frey et al. | Jun 2021 | B2 |
11051830 | Jaramaz et al. | Jul 2021 | B2 |
11071592 | McGuan et al. | Jul 2021 | B2 |
11083525 | Varadarajan et al. | Aug 2021 | B2 |
11090161 | Hodorek | Aug 2021 | B2 |
11129678 | Park | Sep 2021 | B2 |
11134963 | Buza et al. | Oct 2021 | B2 |
11141276 | Kehres | Oct 2021 | B2 |
11166733 | Neichel et al. | Nov 2021 | B2 |
11166764 | Roh et al. | Nov 2021 | B2 |
11179249 | Deransart et al. | Nov 2021 | B2 |
11185417 | Boileau et al. | Nov 2021 | B2 |
11202675 | Uhde et al. | Dec 2021 | B2 |
11213305 | Iannotti et al. | Jan 2022 | B2 |
11234721 | Gargac et al. | Feb 2022 | B2 |
11253323 | Hughes et al. | Feb 2022 | B2 |
11278299 | Neichel et al. | Mar 2022 | B2 |
11278413 | Lang | Mar 2022 | B1 |
11298118 | Koo | Apr 2022 | B1 |
11298140 | Wilkinson et al. | Apr 2022 | B2 |
11298142 | Park et al. | Apr 2022 | B2 |
11298188 | Kehres et al. | Apr 2022 | B2 |
11298189 | Kelman et al. | Apr 2022 | B2 |
11337762 | McKinnon et al. | May 2022 | B2 |
11344370 | Park et al. | May 2022 | B2 |
11364127 | Deransart et al. | Jun 2022 | B2 |
11399851 | Neichel et al. | Aug 2022 | B2 |
11399894 | Chaoui et al. | Aug 2022 | B2 |
11410769 | Yildirim | Aug 2022 | B1 |
11419618 | Kehres et al. | Aug 2022 | B2 |
11419680 | Kontaxis et al. | Aug 2022 | B2 |
11432931 | Lang | Sep 2022 | B2 |
11432934 | Couture et al. | Sep 2022 | B2 |
11443846 | Schoenefeld et al. | Sep 2022 | B2 |
11471303 | Christopher | Oct 2022 | B2 |
11488721 | Otto et al. | Nov 2022 | B2 |
11490965 | Bischoff et al. | Nov 2022 | B2 |
11490966 | Roche et al. | Nov 2022 | B2 |
11559403 | Kehres | Jan 2023 | B2 |
11596479 | McGuan et al. | Mar 2023 | B2 |
11602360 | Heilman et al. | Mar 2023 | B2 |
11617591 | Eash | Apr 2023 | B2 |
11621086 | Spångberg et al. | Apr 2023 | B2 |
11622818 | Siemionow et al. | Apr 2023 | B2 |
11653976 | Bonny et al. | May 2023 | B2 |
11660197 | Lang | May 2023 | B1 |
11696833 | Casey et al. | Jul 2023 | B2 |
11712302 | Walch | Aug 2023 | B2 |
11717412 | Casey et al. | Aug 2023 | B2 |
11730497 | Iannotti et al. | Aug 2023 | B2 |
11737883 | Metcalfe et al. | Aug 2023 | B2 |
11751946 | Gangwar et al. | Sep 2023 | B2 |
11752000 | Terrill | Sep 2023 | B2 |
11766268 | Iannotti et al. | Sep 2023 | B2 |
11766336 | Penninger et al. | Sep 2023 | B2 |
11819415 | Metcalfe et al. | Nov 2023 | B2 |
11847755 | Park et al. | Dec 2023 | B2 |
11850158 | Simoes et al. | Dec 2023 | B2 |
11883040 | Bonin, Jr. et al. | Jan 2024 | B2 |
20010047210 | Wolf | Nov 2001 | A1 |
20020007294 | Bradbury et al. | Jan 2002 | A1 |
20020082741 | Mazumder et al. | Jun 2002 | A1 |
20030028253 | Stone et al. | Feb 2003 | A1 |
20030074080 | Murray | Apr 2003 | A1 |
20030139818 | Rogers et al. | Jul 2003 | A1 |
20040039259 | Krause et al. | Feb 2004 | A1 |
20040064189 | Maroney et al. | Apr 2004 | A1 |
20040102866 | Harris et al. | May 2004 | A1 |
20040133276 | Lang et al. | Jul 2004 | A1 |
20040138754 | Lang et al. | Jul 2004 | A1 |
20040171924 | Mire et al. | Sep 2004 | A1 |
20040181144 | Cinquin et al. | Sep 2004 | A1 |
20040199258 | Macara | Oct 2004 | A1 |
20040236424 | Berez et al. | Nov 2004 | A1 |
20040243481 | Bradbury et al. | Dec 2004 | A1 |
20050049709 | Tornier | Mar 2005 | A1 |
20050065617 | Barrera et al. | Mar 2005 | A1 |
20050065628 | Roose | Mar 2005 | A1 |
20050087047 | Farrar | Apr 2005 | A1 |
20050098915 | Long et al. | May 2005 | A1 |
20050112397 | Rolfe et al. | May 2005 | A1 |
20050197814 | Aram | Sep 2005 | A1 |
20050216305 | Funderud | Sep 2005 | A1 |
20060079963 | Hansen | Apr 2006 | A1 |
20060095047 | de la Barrera | May 2006 | A1 |
20060136058 | Pietrzak | Jun 2006 | A1 |
20060161167 | Myers et al. | Jul 2006 | A1 |
20070089518 | Ericson et al. | Apr 2007 | A1 |
20070118055 | McCombs | May 2007 | A1 |
20070118243 | Schroeder et al. | May 2007 | A1 |
20070173945 | Wiley et al. | Jul 2007 | A1 |
20070191741 | Tsai et al. | Aug 2007 | A1 |
20070198022 | Lang et al. | Aug 2007 | A1 |
20070198094 | Berelsman et al. | Aug 2007 | A1 |
20070203605 | Melton et al. | Aug 2007 | A1 |
20070233141 | Park et al. | Oct 2007 | A1 |
20070244563 | Roche et al. | Oct 2007 | A1 |
20070249967 | Buly et al. | Oct 2007 | A1 |
20080014082 | Kunz et al. | Jan 2008 | A1 |
20080109000 | Maroney et al. | May 2008 | A1 |
20080140209 | Iannotti et al. | Jun 2008 | A1 |
20080183297 | Boileau et al. | Jul 2008 | A1 |
20080228269 | McLeod et al. | Sep 2008 | A1 |
20080243127 | Lang et al. | Oct 2008 | A1 |
20080269596 | Revie et al. | Oct 2008 | A1 |
20080269906 | Iannotti et al. | Oct 2008 | A1 |
20080281328 | Lang et al. | Nov 2008 | A1 |
20080281329 | Fitz et al. | Nov 2008 | A1 |
20080281426 | Fitz et al. | Nov 2008 | A1 |
20080287954 | Kunz et al. | Nov 2008 | A1 |
20090089034 | Penney et al. | Apr 2009 | A1 |
20090099662 | Splieth et al. | Apr 2009 | A1 |
20090216285 | Ek et al. | Aug 2009 | A1 |
20090226068 | Fitz et al. | Sep 2009 | A1 |
20090264894 | Wasielewski | Oct 2009 | A1 |
20090276045 | Lang | Nov 2009 | A1 |
20090292464 | Fuchs et al. | Nov 2009 | A1 |
20090318929 | Tornier et al. | Dec 2009 | A1 |
20100023015 | Park | Jan 2010 | A1 |
20100082035 | Keefer | Apr 2010 | A1 |
20100087927 | Roche et al. | Apr 2010 | A1 |
20100114326 | Winslow et al. | May 2010 | A1 |
20100160917 | Fitz et al. | Jun 2010 | A1 |
20100191100 | Anderson et al. | Jul 2010 | A1 |
20100217270 | Polinski et al. | Aug 2010 | A1 |
20100222781 | Collazo et al. | Sep 2010 | A1 |
20100292963 | Schroeder | Nov 2010 | A1 |
20100303313 | Lang et al. | Dec 2010 | A1 |
20100305573 | Fitz et al. | Dec 2010 | A1 |
20100305574 | Fitz et al. | Dec 2010 | A1 |
20110029088 | Rauscher et al. | Feb 2011 | A1 |
20110035013 | Winslow et al. | Feb 2011 | A1 |
20110040334 | Kaes et al. | Feb 2011 | A1 |
20110046735 | Metzger et al. | Feb 2011 | A1 |
20110054478 | Vanasse et al. | Mar 2011 | A1 |
20110118846 | Katrana et al. | May 2011 | A1 |
20110119884 | Ratron | May 2011 | A1 |
20110137427 | Lappin et al. | Jun 2011 | A1 |
20110152869 | Ek et al. | Jun 2011 | A1 |
20110166661 | Boileau et al. | Jul 2011 | A1 |
20110190775 | Ure | Aug 2011 | A1 |
20110295329 | Fitz et al. | Dec 2011 | A1 |
20110304332 | Mahfouz | Dec 2011 | A1 |
20120010711 | Antonyshyn et al. | Jan 2012 | A1 |
20120041446 | Wong et al. | Feb 2012 | A1 |
20120041564 | Landon | Feb 2012 | A1 |
20120078258 | Lo et al. | Mar 2012 | A1 |
20120101503 | Lang et al. | Apr 2012 | A1 |
20120116203 | Vancraen et al. | May 2012 | A1 |
20120130434 | Stemniski | May 2012 | A1 |
20120141034 | Iannotti et al. | Jun 2012 | A1 |
20120143267 | Iannotti | Jun 2012 | A1 |
20120245647 | Kunz et al. | Sep 2012 | A1 |
20120253350 | Anthony et al. | Oct 2012 | A1 |
20120253467 | Frankle | Oct 2012 | A1 |
20120276509 | Iannotti et al. | Nov 2012 | A1 |
20120279933 | Hensler et al. | Nov 2012 | A1 |
20120289965 | Gelaude et al. | Nov 2012 | A1 |
20120290272 | Bryan | Nov 2012 | A1 |
20120296339 | Iannotti et al. | Nov 2012 | A1 |
20120303035 | Geebelen | Nov 2012 | A1 |
20130024580 | Tsai et al. | Jan 2013 | A1 |
20130053968 | Nardini et al. | Feb 2013 | A1 |
20130110116 | Kehres et al. | May 2013 | A1 |
20130110471 | Lang et al. | May 2013 | A1 |
20130114873 | Chaoui | May 2013 | A1 |
20130172898 | Iannotti et al. | Jul 2013 | A1 |
20130190882 | Humphrey | Jul 2013 | A1 |
20130204375 | Winslow et al. | Aug 2013 | A1 |
20130211531 | Steines et al. | Aug 2013 | A1 |
20130261629 | Anthony et al. | Oct 2013 | A1 |
20130274752 | Trouilloud et al. | Oct 2013 | A1 |
20130325134 | Viscardi et al. | Dec 2013 | A1 |
20130338673 | Keppler | Dec 2013 | A1 |
20140039633 | Roche et al. | Feb 2014 | A1 |
20140074246 | Huebner et al. | Mar 2014 | A1 |
20140159282 | Smith et al. | Jun 2014 | A1 |
20140163564 | Bollinger | Jun 2014 | A1 |
20140236304 | Hodorek et al. | Aug 2014 | A1 |
20140257304 | Eash | Sep 2014 | A1 |
20140257499 | Winslow et al. | Sep 2014 | A1 |
20140276867 | Kelley et al. | Sep 2014 | A1 |
20140303938 | Schoenefeld et al. | Oct 2014 | A1 |
20140303990 | Schoenefeld et al. | Oct 2014 | A1 |
20140371863 | Vanasse et al. | Dec 2014 | A1 |
20150045903 | Neal | Feb 2015 | A1 |
20150052586 | Mills | Feb 2015 | A1 |
20150093283 | Miller et al. | Apr 2015 | A1 |
20150105787 | Tornier et al. | Apr 2015 | A1 |
20150112348 | Schoenefeld et al. | Apr 2015 | A1 |
20150150688 | Vanasse et al. | Jun 2015 | A1 |
20150190151 | Budhabbatti et al. | Jul 2015 | A1 |
20150223941 | Lang | Aug 2015 | A1 |
20150250552 | Radermacher et al. | Sep 2015 | A1 |
20150250597 | Lang et al. | Sep 2015 | A1 |
20150250601 | Humphrey | Sep 2015 | A1 |
20150265411 | Deransart et al. | Sep 2015 | A1 |
20150320430 | Kehres et al. | Nov 2015 | A1 |
20150328004 | Mafhouz | Nov 2015 | A1 |
20150342739 | Mahfouz | Dec 2015 | A1 |
20160015466 | Park et al. | Jan 2016 | A1 |
20160030196 | Eraly et al. | Feb 2016 | A1 |
20160051367 | Gervasi et al. | Feb 2016 | A1 |
20160067049 | Flaherty et al. | Mar 2016 | A1 |
20160074052 | Keppler et al. | Mar 2016 | A1 |
20160100907 | Gomes | Apr 2016 | A1 |
20160120555 | Bonin, Jr. et al. | May 2016 | A1 |
20160136904 | Murai et al. | May 2016 | A1 |
20160143744 | Bojarski et al. | May 2016 | A1 |
20160143749 | Holovacs et al. | May 2016 | A1 |
20160157937 | Kehres et al. | Jun 2016 | A1 |
20160166392 | Vanasse et al. | Jun 2016 | A1 |
20160184104 | Sperling | Jun 2016 | A1 |
20160192951 | Gelaude et al. | Jul 2016 | A1 |
20160193051 | Budhabhatti et al. | Jul 2016 | A1 |
20160213385 | Iannotti et al. | Jul 2016 | A1 |
20160242933 | Deransart et al. | Aug 2016 | A1 |
20160256222 | Walch | Sep 2016 | A1 |
20160270854 | Chaoui et al. | Sep 2016 | A1 |
20160296285 | Chaoui et al. | Oct 2016 | A1 |
20160296290 | Furrer et al. | Oct 2016 | A1 |
20160324648 | Hodorek et al. | Nov 2016 | A1 |
20160331467 | Slamin et al. | Nov 2016 | A1 |
20160345987 | Guilloux et al. | Dec 2016 | A1 |
20160374697 | Kehres et al. | Dec 2016 | A1 |
20170000614 | Mahfouz | Jan 2017 | A1 |
20170000615 | Mahfouz | Jan 2017 | A1 |
20170007330 | Britton et al. | Jan 2017 | A1 |
20170027587 | Fraone et al. | Feb 2017 | A1 |
20170027593 | Bojarski et al. | Feb 2017 | A1 |
20170027702 | Goldstein et al. | Feb 2017 | A1 |
20170035513 | Mahfouz et al. | Feb 2017 | A1 |
20170056024 | Chao | Mar 2017 | A1 |
20170056187 | Humphrey et al. | Mar 2017 | A1 |
20170071748 | Humphrey | Mar 2017 | A1 |
20170079803 | Lang | Mar 2017 | A1 |
20170105841 | Vanasse et al. | Apr 2017 | A1 |
20170105843 | Britton et al. | Apr 2017 | A1 |
20170112626 | Miller et al. | Apr 2017 | A1 |
20170119531 | Bojarski et al. | May 2017 | A1 |
20170143499 | Phipps | May 2017 | A1 |
20170150978 | Iannotti et al. | Jun 2017 | A1 |
20170151058 | Sperling | Jun 2017 | A1 |
20170216038 | Lang et al. | Aug 2017 | A1 |
20170231783 | Lang et al. | Aug 2017 | A1 |
20170249440 | Lang et al. | Aug 2017 | A1 |
20170258598 | Radermacher et al. | Sep 2017 | A1 |
20170273795 | Neichel et al. | Sep 2017 | A1 |
20170273800 | Emerick et al. | Sep 2017 | A1 |
20170273801 | Hodorek | Sep 2017 | A1 |
20170281357 | Taylor et al. | Oct 2017 | A1 |
20170296347 | Chua et al. | Oct 2017 | A1 |
20170304063 | Hatzidakis et al. | Oct 2017 | A1 |
20170340449 | Deransart et al. | Nov 2017 | A1 |
20170360567 | Fitz et al. | Dec 2017 | A1 |
20170367766 | Mahfouz | Dec 2017 | A1 |
20170367828 | Steines et al. | Dec 2017 | A1 |
20170367834 | Fitz et al. | Dec 2017 | A1 |
20180014835 | Lo et al. | Jan 2018 | A1 |
20180028325 | Bojarski et al. | Feb 2018 | A1 |
20180036019 | Iannotti et al. | Feb 2018 | A1 |
20180161176 | Vivanz et al. | Jun 2018 | A1 |
20180228614 | Lang et al. | Aug 2018 | A1 |
20180233222 | Daley et al. | Aug 2018 | A1 |
20180235642 | Amis et al. | Aug 2018 | A1 |
20180235706 | Asseln et al. | Aug 2018 | A1 |
20180235762 | Radermacher et al. | Aug 2018 | A1 |
20180263782 | Lang et al. | Sep 2018 | A1 |
20180289380 | Mauldin et al. | Oct 2018 | A1 |
20180325526 | Haddad | Nov 2018 | A1 |
20190000629 | Winslow | Jan 2019 | A1 |
20190015113 | Morvan | Jan 2019 | A1 |
20190015116 | Neichel et al. | Jan 2019 | A1 |
20190015117 | Neichel et al. | Jan 2019 | A1 |
20190015118 | Neichel et al. | Jan 2019 | A1 |
20190015119 | Athwal et al. | Jan 2019 | A1 |
20190015221 | Neichel et al. | Jan 2019 | A1 |
20190021866 | Vanasse et al. | Jan 2019 | A1 |
20190029757 | Roh et al. | Jan 2019 | A1 |
20190038360 | Chaoui | Feb 2019 | A1 |
20190069913 | Iannotti et al. | Mar 2019 | A1 |
20190090952 | Bonny et al. | Mar 2019 | A1 |
20190142519 | Siemionow et al. | May 2019 | A1 |
20190175354 | Knox et al. | Jun 2019 | A1 |
20190201005 | Schoenefeld et al. | Jul 2019 | A1 |
20190269415 | Lo et al. | Sep 2019 | A1 |
20190365473 | Kehres et al. | Dec 2019 | A1 |
20200030034 | Kontaxis et al. | Jan 2020 | A1 |
20200078180 | Casey | Mar 2020 | A1 |
20200113632 | Varadarajan et al. | Apr 2020 | A1 |
20200155323 | Lang et al. | May 2020 | A1 |
20200170802 | Casey | Jun 2020 | A1 |
20200188121 | Boux De Casson et al. | Jun 2020 | A1 |
20200188134 | Mullen et al. | Jun 2020 | A1 |
20200281728 | Kulper et al. | Sep 2020 | A1 |
20200289276 | Lefebvre et al. | Sep 2020 | A1 |
20200330161 | Chaoui et al. | Oct 2020 | A1 |
20200405330 | Bonin, Jr. et al. | Dec 2020 | A1 |
20210030477 | Zuhars et al. | Feb 2021 | A1 |
20210045888 | Sbaiz et al. | Feb 2021 | A1 |
20210068844 | Lo et al. | Mar 2021 | A1 |
20210085475 | Hodorek et al. | Mar 2021 | A1 |
20210128179 | Dupuis et al. | May 2021 | A1 |
20210128244 | Couture et al. | May 2021 | A1 |
20210196290 | Iannotti et al. | Jul 2021 | A1 |
20210228277 | Chaoui et al. | Jul 2021 | A1 |
20210228371 | Deransart et al. | Jul 2021 | A1 |
20210228372 | Knox et al. | Jul 2021 | A1 |
20210259844 | Penninger et al. | Aug 2021 | A1 |
20210307833 | Farley et al. | Oct 2021 | A1 |
20210307911 | Metcalfe et al. | Oct 2021 | A1 |
20210315642 | McGuan et al. | Oct 2021 | A1 |
20210322130 | Penney et al. | Oct 2021 | A1 |
20210330389 | Varadarajan et al. | Oct 2021 | A1 |
20210338435 | Hodorek | Nov 2021 | A1 |
20210386435 | Buza et al. | Dec 2021 | A1 |
20220022895 | Neichel et al. | Jan 2022 | A1 |
20220031475 | Deransart et al. | Feb 2022 | A1 |
20220047278 | Fitz et al. | Feb 2022 | A1 |
20220054197 | Plessers et al. | Feb 2022 | A1 |
20220096240 | Neichel et al. | Mar 2022 | A1 |
20220110644 | Gargac et al. | Apr 2022 | A1 |
20220110685 | McGuan et al. | Apr 2022 | A1 |
20220125515 | McGuan et al. | Apr 2022 | A1 |
20220148454 | Jaramaz et al. | May 2022 | A1 |
20220160376 | Neichel et al. | May 2022 | A1 |
20220160405 | Casey et al. | May 2022 | A1 |
20220160439 | Ryan et al. | May 2022 | A1 |
20220183757 | Caldera et al. | Jun 2022 | A1 |
20220202497 | Janna et al. | Jun 2022 | A1 |
20220211507 | Simoes et al. | Jul 2022 | A1 |
20220249168 | Besier et al. | Aug 2022 | A1 |
20220257321 | Kehres et al. | Aug 2022 | A1 |
20220273450 | Steines et al. | Sep 2022 | A1 |
20220287850 | Daudet | Sep 2022 | A1 |
20220296259 | Shah | Sep 2022 | A1 |
20220313440 | Metcalfe et al. | Oct 2022 | A1 |
20220330957 | Neichel et al. | Oct 2022 | A1 |
20220338933 | Metcalfe et al. | Oct 2022 | A1 |
20220338998 | Sperling | Oct 2022 | A1 |
20220346968 | Pettersson et al. | Nov 2022 | A1 |
20220351828 | Chaoui | Nov 2022 | A1 |
20220354658 | Knox et al. | Nov 2022 | A1 |
20220370142 | Schoenefeld et al. | Nov 2022 | A1 |
20220387110 | Chaoui | Dec 2022 | A1 |
20220395376 | Poon et al. | Dec 2022 | A1 |
20230000645 | Christopher | Jan 2023 | A1 |
20230045575 | Lang et al. | Feb 2023 | A1 |
20230048940 | Kontaxis et al. | Feb 2023 | A1 |
20230061695 | Couture et al. | Mar 2023 | A1 |
20230079807 | Metcalfe et al. | Mar 2023 | A1 |
20230085093 | Chaoui et al. | Mar 2023 | A1 |
20230109478 | Chaoui et al. | Apr 2023 | A1 |
20230139531 | Roche et al. | May 2023 | A1 |
20230148085 | Paul et al. | May 2023 | A1 |
20230181257 | McGuan et al. | Jun 2023 | A1 |
20230248435 | Bonny et al. | Aug 2023 | A1 |
20230317298 | Spångberg et al. | Oct 2023 | A1 |
20230329791 | Chaoui et al. | Oct 2023 | A1 |
20230346397 | Iannotti et al. | Nov 2023 | A1 |
20230346480 | Walch | Nov 2023 | A1 |
20230355401 | Metcalfe et al. | Nov 2023 | A1 |
20230363915 | Metcalfe et al. | Nov 2023 | A1 |
20230372018 | Gangwar et al. | Nov 2023 | A1 |
20230372111 | Terrill | Nov 2023 | A1 |
Number | Date | Country |
---|---|---|
2021203700 | Aug 2023 | AU |
2927086 | Apr 2015 | CA |
2927811 | Apr 2015 | CA |
2938709 | May 2015 | CA |
3203261 | Jul 2022 | CA |
1 249 213 | Oct 2002 | EP |
1 265 555 | Dec 2002 | EP |
1 563 810 | Aug 2005 | EP |
1 862 151 | Dec 2007 | EP |
1 902 689 | Mar 2008 | EP |
1 952 788 | Aug 2008 | EP |
2 135 576 | Dec 2009 | EP |
1 917 051 | Jun 2010 | EP |
2 243 445 | Oct 2010 | EP |
2 324 801 | May 2011 | EP |
2 501 313 | Sep 2012 | EP |
2 544 601 | Jan 2013 | EP |
2583242 | Apr 2013 | EP |
1858430 | Oct 2013 | EP |
2471483 | Oct 2013 | EP |
2670314 | Aug 2014 | EP |
2 845 547 | Mar 2015 | EP |
2 965 720 | Jan 2016 | EP |
1323395 | Aug 2016 | EP |
3057518 | Aug 2016 | EP |
3057524 | Aug 2016 | EP |
3065671 | Sep 2016 | EP |
3068317 | Sep 2016 | EP |
2 874 570 | Jan 2017 | EP |
3 117 801 | Jan 2017 | EP |
2244654 | Mar 2017 | EP |
2770920 | Jul 2017 | EP |
2770919 | Aug 2017 | EP |
2303192 | Nov 2018 | EP |
3760142 | Jan 2021 | EP |
3248553 | Mar 2021 | EP |
3845154 | Jul 2021 | EP |
3481318 | Sep 2022 | EP |
2 579 454 | Oct 1986 | FR |
2 859 099 | Mar 2005 | FR |
2962573 | Jan 2012 | FR |
2982694 | Nov 2016 | FR |
2982979 | Nov 2016 | FR |
2982693 | Dec 2016 | FR |
2501494 | Oct 2013 | GB |
3179628 | Nov 2012 | JP |
WO 93025157 | Dec 1993 | WO |
WO 0035346 | Jun 2000 | WO |
WO 0059411 | Oct 2000 | WO |
WO 02061688 | Aug 2002 | WO |
2005016123 | Feb 2005 | WO |
WO-2006106419 | Oct 2006 | WO |
2008021494 | Feb 2008 | WO |
2008117028 | Oct 2008 | WO |
WO 2010120346 | Oct 2010 | WO |
WO 2011110374 | Sep 2011 | WO |
2011142998 | Nov 2011 | WO |
WO 2011154891 | Dec 2011 | WO |
WO 2011157961 | Dec 2011 | WO |
WO 2012021241 | Feb 2012 | WO |
WO 2012058349 | May 2012 | WO |
WO 2012125319 | Sep 2012 | WO |
2012141790 | Oct 2012 | WO |
2012170376 | Dec 2012 | WO |
WO 2013060851 | May 2013 | WO |
WO 2013062848 | May 2013 | WO |
WO 2013062851 | May 2013 | WO |
WO-2013060851 | May 2013 | WO |
WO 2013142998 | Oct 2013 | WO |
WO 2014020561 | Feb 2014 | WO |
WO 2014035991 | Mar 2014 | WO |
2014145267 | Sep 2014 | WO |
WO 2014180972 | Nov 2014 | WO |
2015018921 | Feb 2015 | WO |
WO 2015052586 | Apr 2015 | WO |
WO 2015056097 | Apr 2015 | WO |
2015071757 | May 2015 | WO |
WO 2015068035 | May 2015 | WO |
WO 2015071757 | May 2015 | WO |
WO 2015175397 | Nov 2015 | WO |
WO 2015185219 | Dec 2015 | WO |
WO 2017091657 | Jun 2017 | WO |
WO 2017105815 | Jun 2017 | WO |
WO 2017106294 | Jun 2017 | WO |
WO 2017184792 | Oct 2017 | WO |
WO 2017214537 | Dec 2017 | WO |
WO 2018022227 | Feb 2018 | WO |
WO 2019014278 | Jan 2019 | WO |
WO 2019014281 | Jan 2019 | WO |
WO 2019033037 | Feb 2019 | WO |
Entry |
---|
US 9,451,972 B2, 09/2016, Lang et al. (withdrawn) |
Communication Pursuant to Article 94(3) issued in connection with European Patent Application No. 19759204.1, dated May 9, 2023, 6 pages. |
Boileau, et al., “The three-dimensional geometry of the proximal humerus: implications for surgical technique and prosthetic design.” The Journal of bone and joint surgery. British vol. 79.5 (1997): 857-865. |
Habets, et al., Computer assistance in orthopaedic surgery. Technische Universiteit Eindhoven, 2002. |
Hempfing, et al. “Surgical landmarks to determine humeral head retrotorsion for hemiarthroplasty in fractures.” Journal of shoulder and elbow surgery 10.5 (2001): 460-463. |
Ma, et al., “Robust registration for computer-integrated orthopedic surgery: laboratory validation and clinical experience.” Medical image analysis 7.3 (2003): 237-250. |
“Olympia Total Shoulder System Surgical Technique”, Wright Medical Technology, 2001, in 19 pages. |
Radermacher, K., et al., “Computer Assisted Orthopaedic Surgery with Image Based Individual Templates,” Clinical Orthopaedics and Related Research, No. 354, Sep. 1998, pp. 28-38. |
Radermacher, K., et al., “Image Guided Orthopedic Surgery Using Individual Templates: Experimental Results and Aspects of the Development of a Demonstrator for Pelvis Surgery”, Health Care Sector, Telematics Applications Program, 1997, pp. 606-615. |
Tornier, “Salto Talaris, Total Ankle Prosthesis”, 2009. |
Valstar, et al. “Towards computer-assisted surgery in shoulder joint replacement.” ISPRS journal of photogrammetry and remote sensing 56.5-6 (2002): 326-337. |
Valstar, et al. “The use of Roentgen stereophotogrammetry to study micromotion of orthopaedic implants.” ISPRS journal of photogrammetry and remote sensing 56.5-6 (2002): 376-389. |
Welsh, et al., “CT-based preoperative analysis of scapula morphology and glenohumeral joint geometry.” Computer Aided Surgery 8.5 (2003): 264-268. |
Zimmer, “Zimmer® PSI Shoulder Trabecular MetalTM Reverse Glenoid Base Plate Surgical Technique”, Dec. 30, 2013. |
Extended European Search Report issued in EP Application No. 18187134.4, dated Nov. 22, 2018 in 6 pages. |
International Search Report and Written Opinion for PCT/IB2014/002711 dated Mar. 23, 2015 in 12 pages. |
Dougherty, “Digital Image Processing for Medical Applications,” May 11, 2009 (May 11, 2009), Cambridge University Press, XP002615721. |
Gregory, et al.,“Accuracy of Glenoid Component Placement in Total Shoulder Arthroplasty and Its Effect on Clinical and Radiological Outcome in a Retrospective, Longitudinal, Monocentric Open Study,” PLOS One, p. e75791, Aug. 1, 2013, vol. 8, No. 10. |
Iannotti et al., “Prosthetic positioning in total shoulder arthroplasty,” Journal of Shoulder and Elbow Surgery, Jan. 1, 2005, vol. 14, No. 1S, pp. S111-S121. |
Kobashi et al., “Knowledge-Based Organ Identification from CT Images,” Pattern Recognition, Elsevier, GB, vol. 28, No. 4, Apr. 1, 1995 (Apr. 1, 1995), pp. 475-491, XP004013165. |
Lee, C.C. et al., “Identifying multiple abdominal organs from CT image series using a multimodule contextual neural network and spatial fuzzy rules”, IEEE Transactions on Information Technology in Biomedicine, IEEE Services Center, Los Alamitos, CA, US, vol. 7, No. 3, Sep. 1, 2003 (Sep. 1, 2003) pp. 208-217, XP011100536. |
Wu, et al. “An interface for the data exchange between CAS and CAD/CAM systems.” International Congress Series. vol. 1256. Elsevier, 2003. |
Non-Final Office Action issued in connection with U.S. Appl. No. 16/904,345, filed Feb. 15, 2022, 35 pages. |
First Office Action issued in corresponding Japanese Patent Application No. 2021-506973, dated Jun. 5, 2023, 5 pages. |
Non-Final Office Action issued in connection with U.S. Appl. No. 16/910,663, filed Dec. 15, 2022, 9 pages. |
Non-Final Office Action issued in connection with U.S. Appl. No. 17/359,745, Nov. 26, 2023, 7 pages. |
Final Office Action issued in connection with U.S. Appl. No. 16/910,663, Nov. 16, 2023, 9 pages. |
Communication Pursuant to Article 94(3) issued in connection with European Patent Application No. 18746503.4, Oct. 17, 2023, 5 pages. |
Non-Final Office Action issued in connection with U.S. Appl. No. 17/650,722, Nov. 15, 2023, 10 pages. |
Notice of Allowance issued in connection with U.S. Appl. No. 17/645,607, Dec. 20, 2023, 11 pages. |
Notice of Allowance issued in connection with U.S. Appl. No. 16/648,128, Feb. 16, 2024, 9 pages. |
First Examination Report from counterpart Australian Application No. 2021201702 dated Dec. 1, 2021, 2 pp. |
Marker et al., “Contour-Based Surface Reconstruction using Implicit Curve Fitting, and Distance Field Filtering and Interpolation,” vol. Graphics, Jan. 2006, 9 pp. |
Nguyen et al., “Design and Development of a Computer Assisted Glenoid Implantation Technique for Shoulder Replacement Surgery,” Computer Aided Surgery, vol. 12, No. 3, May 2007, pp. 152-159. |
First Examination Report issued in connection with corresponding Australian Patent Application No. 2019236696, Jun. 18, 2020, 4 pages. |
International Search Report and Written Opinion of the International Searching Authority issued for PCT Application No. PCT/IB2014/002759 mailed Mar. 27, 2015, 13 pp. |
Notice of Acceptance from counterpart Australian Application No. 2021201702 dated Apr. 1, 2022, 3 pp. |
Notice of Allowance from counterpart Canadian Application No. 2,927,811 dated Jan. 18, 2022, 1 pp. |
Office Action from counterpart Canadian Application No. 2,927,811, dated Apr. 29, 2021, 3 pp. |
Office Action from counterpart Canadian Application No. 2,927,811, dated Nov. 17, 2020, 3 pp. |
Office Action issued in connection with corresponding Canadian Patent Application No. 2,927,811, May 25, 2020, 3 pages. |
Prosecution History from U.S. Appl. No. 15/029,879, dated May 17, 2018 through Dec. 16, 2020, 122 pp. |
Prosecution History from U.S. Appl. No. 17/117,546, dated Dec. 10, 2020 through Mar. 14, 2023, 29 pp. |
Raaijmakers et al., “A Custom-Made Guide-Wire Positioning Device for Hip Surface Replacement Arthroplasty: Description and First Results,” BMC Musculoskeletal Disorders, vol. 11, Jul. 2010, 7 pp. |
Response to Office Action dated Dec. 1, 2021, from counterpart Australian Application No. 2021201702 filed Mar. 30, 2022, 1 pp. |
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Apr. 29, 2021, filed Aug. 26, 2021, 8 pp. |
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated May 25, 2020, filed Sep. 25, 2020, 19 pp. |
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Nov. 17, 2020, filed Mar. 16, 2021, 15 pp. |
Response to Official Action from counterpart Canadian Application No. 2,927,811, dated Oct. 10, 2019, filed Apr. 14, 2020, 11 pp. |
Advisory Action from U.S. Appl. No. 16/918,347 dated Aug. 8, 2023, 2 pp. |
Boissonnat, J.D., “Shape Reconstruction from Planar Cross Sections,” Computer Vision, Graphics, and Image Processing, vol. 44, No. 1, Oct. 1988, 29 pp. |
Communication pursuant to Article 94(3) EPC from counterpart European Application No. 19209711.1 dated Dec. 21, 2022, 4 pp. |
Examination Report No. 1 from counterpart Australian Application No. 2021203700 dated Dec. 1, 2022, 5 pp. |
Extended European Search Report issued in connection with corresponding European Patent Application No. 19209711.1; 12 pages, Mar. 23, 2020. |
Final Office Action from U.S. Appl. No. 16/918,347 dated May 30, 2023, 18 pp. |
First Examination Report from counterpart Australian Patent Application No. 2021209349 dated Oct. 6, 2022, 4 pp. |
First Examination Report issued in connection with Australian Patent Application No. 2019236759 Jul. 17, 2020, 5 pages. |
International Preliminary Report on Patentability from International Application No. PCT/IB2014/002819, dated Apr. 12, 2016, 12 pp. |
International Search Report and Written Opinion of the International Searching Authority issued for PCT Application PCT/IB2014/002819 mailed on May 8, 2015. |
Notice of Acceptance from counterpart Australian Application No. 2019236759, dated Apr. 27, 2021, 114 pp. |
Notice of Acceptance from counterpart Australian Application No. 2021203700, dated Aug. 14, 2023, 41 pp. |
Notice of Allowance from counterpart Canadian Application No. 2,927,086, dated Jul. 22, 2021, 1 pp. |
Notice of Allowance from U.S. Appl. No. 16/918,347 dated Oct. 2, 2023, 2 pp. |
Notice of Allowance from U.S. Appl. No. 16/918,347 dated Sep. 21, 2023, 8 pp. |
Notice of Allowance from U.S. Appl. No. 17/874,452 dated Dec. 4, 2023, 5 pp. |
Notice of Allowance from U.S. Appl. No. 17/874,452 dated Nov. 15, 2023, 8 pp. |
Notice of Allowance from U.S. Appl. No. 17/874,472 dated Feb. 16, 2024, 18 pp. |
Notice of Intent to Grant from counterpart Australian Application No. 2021209349 dated May 12, 2023, 3 pp. |
Office Action from U.S. Appl. No. 16/918,347 dated Oct. 21, 2022, 19 pp. |
Office Action issued in connection with Canadian Patent Application No. 2,927,086, Jan. 20, 2021, 3 pages. |
Office Action issued in connection with corresponding Canadian Patent Application No. 2,927,086, Oct. 16, 2019, 7 pages. |
Office Action issued in connection with European Patent Application No. 19209711.1, Dec. 22, 2020, 5 pages. |
Prosecution History from Australian Patent Application No. 2014333516, dated May 6, 2016 through Oct. 31, 2019, 290 pp. |
Prosecution History from European Patent Application No. 14830864.6, dated Jan. 27, 2015 through Dec. 12, 2019, 307 pp. |
Prosecution History from U.S. Appl. No. 15/028,497, dated Apr. 4, 2018 through Apr. 6, 2020, 103 pp. |
Prosecution History from U.S. Appl. No. 17/229,111, dated Jul. 16, 2021 through Apr. 1, 2022, 53 pp. |
Response to Communication from counterpart European Application No. 19209711.1, dated Dec. 22, 2020, filed Mar. 24, 2021, 14 pp. |
Response to Communication pursuant to Article 94(3) EPC dated Dec. 21, 2022, from counterpart European Application No. 19209711.1 filed Apr. 20, 2023, 25 pp. |
Response to European Search Report from counterpart European Application No. 19209711.1, dated Mar. 23, 2020, filed Oct. 22, 2020, 8 pp. |
Depuy, “Delta CTA Reverse Shoulder Prosthesis” Surgical Technique, Aug. 2004, 28 pages. |
Boileau, et al., “Grammont Reverse Prosthesis: Design, Rationale, and Biomechanics”, J. Shoulder Elbow Surg, Jan./Feb. 2005, 15 pages. |
Frankle, et al., “Glenoid Morphology in Reverse Shoulder Arthroplasty: Classification and Surgical Implications”, Journal of Shoulder and Elbow Surgery, 2009, 18, pp. 874-885, 12 pages. |
Nguyen, et al., “Design and Development of a Computer Assisted Glenoid Implantation Technique for Shoulder Replacement Surgery”, Computer Aided Surgery, May 2007; 12(3): 152-159, 8 pages. |
Botha, Charl. P., “Technical Report: Devide—The Delft Visualisation and Image Processing Development Environment”, May 30, 2005, 59 pages. |
Botha, et al., “Pre-Operative Planning and Intra-Operative Guidance for Shoulder Replacement Surgery”, Scientific Visualization: Advanced Concepts, pp. 179-195, 1998, 17 pages. |
Botha, Charl. P., “Techniques and Software Architectures for Medical Visualisation and Image Processing”, ASCI Dissertation Series No. 117, Sep. 12, 2005, 190 pages. |
Krekel, et al., “Evaluation of Bone Impingement Prediction in Pre-Operative Planning for Shoulder Arthroplasty”, Proc. IMechE. vol. 223 Part H: J. Engineering in Medicine, Oct. 14, 2008, 10 pages. |
Valstar, et al. “Towards Computer-Assisted Surgery in Shoulder Joint Replacement”, ISPRS Journal of Photogrammety & Remote Sensing 56 (2002) pp. 326-337, May 3, 2002, 12 pages. |
Extended European Search Report issued in connection with European Patent Application No. 24162840.3, Jun. 21, 2024, 11 pages. |
Non-Final Office Action issued in connection with U.S. Appl. No. 17/643,436, May 22, 2024, 13 pages. |
Number | Date | Country | |
---|---|---|---|
20220031475 A1 | Feb 2022 | US |
Number | Date | Country | |
---|---|---|---|
61903814 | Nov 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16521466 | Jul 2019 | US |
Child | 17451499 | US | |
Parent | 15024747 | US | |
Child | 16521466 | US |